Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Calixa Therapeutics
Calixa Therapeutics is a biopharmaceutical company focused on developing a novel cephalosporin to combat multi-drug resistant organisms.
Sector
Subsector
Keywords
Location
total rounds
BaroFold
BaroFold is a biopharmaceutical company focused on developing protein therapeutics for immunology indications.
Sector
Subsector
Keywords
Location
total rounds
total raised
Sutro Biopharma
Sutro Biopharma develops protein therapeutics using its proprietary XpressCF platform to treat cancer and autoimmune disorders.
Sector
Subsector
Location
total rounds
total raised
Coherus Biosciences
Coherus Biosciences develops and sells biologic therapeutics for oncology and inflammatory diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 18.02.2021. Their latest investor Cybele Holdings. Their latest round Post-IPO Equity
Pfizer
Pfizer is a company that provides safe, effective, and affordable medicines and healthcare services.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Co-Investors
Investors11
Number of lead investors
Number of investors
Cybele Holdings
Cybele Group offers consulting, financial services, investment banking, brokerage, and asset management.
Sector
Subsector
Location
count Of Investments
count Of Exists
Office of the Chief Scientist
The represented Corporate Investor is a venture capital firm based in Tel Aviv.
Sector
Subsector
Location
count Of Investments
count Of Exists
Tamares
Tamares is a private investment group with diverse interests in real estate, technology, manufacturing, leisure, and media.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Yoseph Shaaltiel
Dr. Shaaltiel founded Protalix Ltd. in 1993 and has served as our Vice President, Research and Development since December 31, 2006. Prior to establishing Protalix, Dr. Shaaltiel was a Research Associate at the MIGAL Technological Center. He also served as Deputy Head of the Biology Department of the Biological and Chemical Center of the Israeli Defense Forces and as a Biochemist at Makor Chemicals Ltd. Dr. Shaaltiel was a Postdoctoral Fellow at the University of California at Berkeley and at Rutgers University in New Jersey. He has co-authored over 40 articles and abstracts on plant biochemistry and holds seven patents. Dr. Shaaltiel received his Ph.D. in Plant Biochemistry from the Weizmann Institute of Science, an M.Sc. in Biochemistry from the Hebrew University and a B.Sc. in Biology from the Ben Gurion University.
current job
organization founded
Yoseph Shaaltiel
Employee Profiles6
Yoseph Shaaltiel
Founder & Executive Vice President, Research and Development
Activity
Recent News6
The graph reveals the ratio (%) of positive news articles in a chosen time range